FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana has been…
Technology
Deep-brain stimulation: Hope for dystonia patients
Deep-brain stimulation can make a significant difference in the lives of patients with dystonia.
Maximize your reprocessing program
Reprocessing can help an organization save money and protect the environment.
Virtual visiting: The next best thing to being there
The author explains how virtual visiting helps keep patients connected with loved ones around the country or even the world.
How to identify atrioventricular blocks
These arrhythmias can be tricky to interpret on a rhythm strip. The author guides you through the basics.
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed…
FDA approves new silicone breast implant
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant for…
FDA approves first retinal implant for adults with advanced retinitis pigmentosa
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device to treat…
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia (pain during…
FDA warns of potential risk of liver injury in ADPKD patients taking Samsca
On Jan. 25, 2013, the U.S. Food and Drug Administration notified healthcare professionals of significant liver injury associated with the use of Samsca in…
FDA approves new drug treatments for type 2 diabetes
On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina…
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana…
Deep-brain stimulation: Hope for dystonia patients
Deep-brain stimulation can make a significant difference in the lives of patients with dystonia.
Maximize your reprocessing program
Reprocessing can help an organization save money and protect the environment.
Virtual visiting: The next best thing to being there
The author explains how virtual visiting helps keep patients connected with loved ones around the country or even the world.
How to identify atrioventricular blocks
These arrhythmias can be tricky to interpret on a rhythm strip. The author guides you through the basics.
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease…
FDA approves new silicone breast implant
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast…
FDA approves first retinal implant for adults with advanced retinitis pigmentosa
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device…
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia…
FDA warns of potential risk of liver injury in ADPKD patients taking Samsca
On Jan. 25, 2013, the U.S. Food and Drug Administration notified healthcare professionals of significant liver injury associated with the use of…
FDA approves new drug treatments for type 2 diabetes
On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2…
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
Test Your Knowledge
Wegovy TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.